Gene · 27102
Papers1,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated stress response activation in combination PG3 and cisplatin-treated TP53-mutated head and neck squamous carcinoma cells induces potent apoptotic response. | bioRxiv | 2026 | 42818268 | PubTator, text mining | PubMed |
| Mitochondrial complex I and II inhibiting pesticides activate DELE1-HRI integrated stress signaling but engage distinct cell death programs in human neuronal cells. | Toxicol Appl Pharmacol | 2026 | 42594974 | PubTator, text mining | PubMed |
| An ancient mitochondrial program tunes translation to haem availability. | Nature | 2026 | 42557333 | PubTator, text mining | PubMed |
| EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia. | Am J Hematol | 2026 | 42403074 | PubTator, text mining | PubMed |
| Metformin Partially Attenuates Simvastatin-Induced Myotoxic Responses in C2C12 Myotubes Through Metabolic Adaptation. | FASEB J | 2026 | 42361123 | PubTator, text mining | PubMed |
| Regulatory mechanism of heme-regulated inhibitor through autophosphorylation-driven activation and heme-induced deactivation. | J Biochem | 2026 | 42350899 | PubTator, text mining | PubMed |
| Mitochondrial integrated stress response activation creates a therapeutic vulnerability to MCL-1 inhibition in acute myeloid leukemia. | Cell Death Dis | 2026 | 42350371 | PubTator, text mining | PubMed |
| Understanding the OMA1-DELE1-HRI Axis and PINK1-parkin-mediated Mitophagy in Parkinson's Disease. | CNS Neurol Disord Drug Targets | 2026 | 42261169 | PubTator, text mining | PubMed |
| Iron: Regulation, redox homeostasis, and ferroptosis in cancer. | Ferroptosis Oxid Stress | 2026 | 42099806 | PubTator, text mining | PubMed |
| The integrated stress response in cancer: mechanisms of tumor adaptation and therapeutic targeting. | Biochem Soc Trans | 2026 | 42043015 | PubTator, text mining | PubMed |
| The heme-regulated inhibitor eIF2α kinase: a multifaceted sensor and drug target. | Trends Cell Biol | 2026 | 41991349 | PubTator, text mining | PubMed |
| Overcoming immunotherapy resistance in breast cancer: a novel strategy by targeting the integrated stress response. | Front Cell Dev Biol | 2026 | 41938533 | PubTator, text mining | PubMed |
| Stress granules at the crossroads of retroviral replication and antiviral immunity: mechanisms and therapeutic opportunities. | Mol Biol Rep | 2026 | 41931190 | PubTator, text mining | PubMed |
| Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking. | Theranostics | 2026 | 41799204 | PubTator, text mining | PubMed |
| A Cross-Species Hydroquinone Model Replicates Smoking-Related Corneal Endothelial Oxidative Injury and Enables Therapeutic Screening of FGF10. | Invest Ophthalmol Vis Sci | 2026 | 41789845 | PubTator, text mining | PubMed |
| The Yin-Yang of Stress and Senescence: Integrated Stress Response and SASP Crosstalk in Stem Cell Fate, Regeneration, and Disease. | Biocell | 2026 | 41777532 | PubTator, text mining | PubMed |
| Differential assembly of RNP granules via activation of distinct dsRNA sensors by adenovirus mutants. | bioRxiv | 2026 | 41756847 | PubTator, text mining | PubMed |
| RNA-Seq of Gingival Fibroblasts Grown on Collagen Membranes and Hyaluronic Acid. | J Funct Biomater | 2026 | 41745519 | PubTator, text mining | PubMed |
| Pharmacological induction of mitochondrial stress counteracts therapy resistance in glioblastoma stem-like cells. | bioRxiv | 2026 | 41727106 | PubTator, text mining | PubMed |
| De novo design of protein binders that target DELE1 to inhibit the mitochondrial stress response. | bioRxiv | 2026 | 41717097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27102/papers